Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Provider Notice issued 07/28/09

​Preferred Drug List – Basal Insulin

To:​ Participating Medical Assistance Providers​
Date:​ July 28, 2009​
Re:​ Preferred Drug List – Basal Insulin ​

Effective August 6, 2009, Lantus® will replace Levemir® as HFS% preferred basal insulin.  In order to allow adequate time for the transition to the new preferred product, HFS will approve a temporary prior authorization override of Levemir through October 31, 2009, for patients who are presently established on Levemir®. During this transition period, if a prescriber feels that there is a medical reason that a patient cannot switch to Lantus®, the prescriber will need to submit a prior approval request for Levemir® multi-dose vials for that patient.

 

Prior approval may be requested by calling 1-800-252-8942, or by fax at 217-524-0404 or 217-524.7264. Prior approval forms may be found at http://www.illinois.gov/hfs/MedicalProviders/Pharmacy/Pages/DrugPriorApprovalInformation.aspx

 

Questions regarding this notice may be directed to the Bureau of Pharmacy at 1-877-782-5565, Option 7.

 

Theresa A. Eagleson, Administrator

Division of Medical Programs